Cognitive	B:C0338656
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
:	O
a	O
systematic	O
review	O
and	O
meta-analysis	O
.	O

Cognitive	O
impairment	I:C0338656
in	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
:	O
a	O
systematic	O
review	O
and	O
meta-analysis	O
.	O

Cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
:	O
a	O
systematic	O
review	O
and	O
meta-analysis	O
.	O

Cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	B:C0275524
patients	O
:	O
a	O
systematic	O
review	O
and	O
meta-analysis	O
.	O

Cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
:	O
a	O
systematic	O
review	B:C0282443
and	O
meta-analysis	O
.	O

Cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
:	O
a	O
systematic	O
review	O
and	O
meta-analysis	B:C0920317
.	O

Cognitive	B:C0338656
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
)	O
mono	O
-	I:C3714514
infections	I:C3714514
.	O

Cognitive	O
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
)	O
mono	O
-	I:C3714514
infections	I:C3714514
.	O

Cognitive	O
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
)	O
mono	O
-	I:C3714514
infections	I:C3714514
.	O

Cognitive	O
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
)	O
mono	O
-	I:C3714514
infections	I:C3714514
.	O

Cognitive	O
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
)	O
mono	O
-	I:C3714514
infections	I:C3714514
.	O

Cognitive	O
impairment	I:C0338656
has	O
been	O
well	O
documented	O
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
(	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
)	O
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
(	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
)	O
mono	B:C3714514
-	I:C3714514
infections	I:C3714514
.	O

However	O
,	O
in	O
the	O
context	O
of	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
the	O
research	O
is	O
more	O
limited	O
.	O

However	O
,	O
in	O
the	O
context	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
co-infection	O
the	O
research	O
is	O
more	O
limited	O
.	O

However	O
,	O
in	O
the	O
context	O
of	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	B:C0275524
the	O
research	O
is	O
more	O
limited	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	B:C0282443
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	B:C0338656
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	B:C0275524
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	B:C0332128
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	B:C0392335
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
aim	O
of	O
this	O
systematic	O
review	O
was	O
to	O
describe	O
the	O
characteristics	O
of	O
cognitive	O
impairment	I:C0338656
in	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infection	O
and	O
to	O
examine	O
the	O
differences	O
in	O
cognitive	O
performance	I:C0392335
between	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
and	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
and	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
mono	B:C3714514
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Of	O
the	O
437	O
records	O
initially	O
screened	B:C0220908
,	O
24	O
papers	O
met	O
the	O
inclusion	O
criteria	O
and	O
were	O
included	O
in	O
the	O
systematic	O
review	O
.	O

Of	O
the	O
437	O
records	O
initially	O
screened	O
,	O
24	O
papers	O
met	O
the	O
inclusion	O
criteria	O
and	O
were	O
included	O
in	O
the	O
systematic	O
review	B:C0282443
.	O

Four	O
studies	B:C2603343
were	O
included	O
in	O
the	O
meta-	O
analysis	I:C0920317
.	O

Four	O
studies	O
were	O
included	O
in	O
the	O
meta-	B:C0920317
analysis	I:C0920317
.	O

Most	O
studies	B:C2603343
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	B:C0220847
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	B:C0275524
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	B:C0338656
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Most	O
studies	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
/	O
hepatitis	O
C	I:C0220847
virus	I:C0220847
co-infected	O
patients	O
had	O
a	O
higher	O
level	O
of	O
cognitive	O
impairment	I:C0338656
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	B:C3714514
-	I:C3714514
infected	I:C3714514
patients	O
.	O

Meta	B:C0920317
-analysis	I:C0920317
also	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
had	O
a	O
significantly	O
lower	O
global	O
deficit	O
score	O
than	O
co-infected	O
patients	O
.	O

Meta	O
-analysis	I:C0920317
also	O
indicated	O
that	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
had	O
a	O
significantly	O
lower	O
global	O
deficit	O
score	O
than	O
co-infected	O
patients	O
.	O

Meta	O
-analysis	I:C0920317
also	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	B:C3714514
-	I:C3714514
infected	I:C3714514
patients	O
had	O
a	O
significantly	O
lower	O
global	O
deficit	O
score	O
than	O
co-infected	O
patients	O
.	O

Meta	O
-analysis	I:C0920317
also	O
indicated	O
that	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
had	O
a	O
significantly	O
lower	O
global	O
deficit	O
score	O
than	O
co-infected	B:C0275524
patients	O
.	O

The	O
results	O
also	O
indicated	O
that	O
co-infected	B:C0275524
patients	O
were	O
more	O
likely	O
to	O
be	O
impaired	O
in	O
information	O
processing	O
speed	O
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
results	O
also	O
indicated	O
that	O
co-infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
impaired	B:C0338656
in	O
information	O
processing	O
speed	O
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
results	O
also	O
indicated	O
that	O
co-infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
impaired	O
in	O
information	O
processing	O
speed	O
than	O
human	B:C0019682
immunodeficiency	I:C0019682
virus	I:C0019682
mono	O
-	I:C3714514
infected	I:C3714514
patients	O
.	O

The	O
results	O
also	O
indicated	O
that	O
co-infected	O
patients	O
were	O
more	O
likely	O
to	O
be	O
impaired	O
in	O
information	O
processing	O
speed	O
than	O
human	O
immunodeficiency	I:C0019682
virus	I:C0019682
mono	B:C3714514
-	I:C3714514
infected	I:C3714514
patients	O
.	O

These	O
findings	B:C0243095
can	O
be	O
challenged	O
by	O
biasing	O
factors	O
such	O
as	O
the	O
small	O
number	O
of	O
included	O
studies	O
,	O
heterogeneity	O
of	O
the	O
samples	O
and	O
a	O
large	O
diversity	O
of	O
methodological	O
procedures	O
.	O

These	O
findings	O
can	O
be	O
challenged	O
by	O
biasing	O
factors	O
such	O
as	O
the	O
small	O
number	O
of	O
included	O
studies	B:C2603343
,	O
heterogeneity	O
of	O
the	O
samples	O
and	O
a	O
large	O
diversity	O
of	O
methodological	O
procedures	O
.	O

Future	O
research	O
with	O
consistent	O
and	O
comprehensive	O
neuropsychological	B:C0451331
batteries	I:C0451331
and	O
covering	O
a	O
greater	O
diversity	O
of	O
risk	O
factors	I:C0035648
is	O
needed	O
,	O
in	O
order	O
to	O
clarify	O
the	O
effects	O
of	O
both	O
viruses	O
on	O
cognitive	O
function	I:C0392335
and	O
the	O
mechanisms	O
that	O
underlie	O
these	O
effects	O
.	O

Future	O
research	O
with	O
consistent	O
and	O
comprehensive	O
neuropsychological	O
batteries	I:C0451331
and	O
covering	O
a	O
greater	O
diversity	O
of	O
risk	B:C0035648
factors	I:C0035648
is	O
needed	O
,	O
in	O
order	O
to	O
clarify	O
the	O
effects	O
of	O
both	O
viruses	O
on	O
cognitive	O
function	I:C0392335
and	O
the	O
mechanisms	O
that	O
underlie	O
these	O
effects	O
.	O

Future	O
research	O
with	O
consistent	O
and	O
comprehensive	O
neuropsychological	O
batteries	I:C0451331
and	O
covering	O
a	O
greater	O
diversity	O
of	O
risk	O
factors	I:C0035648
is	O
needed	O
,	O
in	O
order	O
to	O
clarify	O
the	O
effects	O
of	O
both	O
viruses	B:C0042776
on	O
cognitive	O
function	I:C0392335
and	O
the	O
mechanisms	O
that	O
underlie	O
these	O
effects	O
.	O

Future	O
research	O
with	O
consistent	O
and	O
comprehensive	O
neuropsychological	O
batteries	I:C0451331
and	O
covering	O
a	O
greater	O
diversity	O
of	O
risk	O
factors	I:C0035648
is	O
needed	O
,	O
in	O
order	O
to	O
clarify	O
the	O
effects	O
of	O
both	O
viruses	O
on	O
cognitive	B:C0392335
function	I:C0392335
and	O
the	O
mechanisms	O
that	O
underlie	O
these	O
effects	O
.	O

Because	O
cognitive	B:C0338656
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	B:C0805586
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	B:C2364172
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	B:C0018727
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	B:C0018726
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	B:C1516615
management	I:C1516615
of	O
these	O
infections	O
.	O

Because	O
cognitive	O
impairments	I:C0338656
may	O
pose	O
significant	O
challenges	O
to	O
medication	O
adherence	I:C2364172
,	O
quality	O
of	O
life	O
and	O
overall	O
functioning	O
,	O
such	O
knowledge	O
may	O
have	O
important	O
implications	O
to	O
the	O
planning	O
and	O
implementation	O
of	O
effective	O
interventions	O
aimed	O
at	O
optimising	O
the	O
clinical	O
management	I:C1516615
of	O
these	O
infections	B:C3714514
.	O

